We’re excited to announce the general availability of Researcher and Analyst, two first-of-their-kind reasoning agents ...

In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin ...

Democratic organizers are hesitant to admit when get-out-the-vote efforts don’t work. One group is trying to change that.

Merck & Co.’s ambition to get the first oral PCSK9 inhibitor to market came one step closer this morning as the pharma ...

The combination of a data center boom, rising gas exports and cuts to clean energy tax breaks could spike American energy ...

On June 7, Islamic Republic of Iran Broadcasting (IRIB), citing informed sources, unveiled the greatest victory of country's ...

The FinOps Foundation has expanded the core scope of its balance sheet to include wider assocuated cloud software costs, ...

As state workers prepare to return to the office four days a week, some California agencies are still hiring for remote ...

Autolus Therapeutics plc delivers a breakthrough CAR-T therapy for B-ALL with strong safety/efficacy. Learn more about AUTL ...

Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Incyte Corporation (NASDAQ:INCY) with a price target of $68 ...

Australia is on the cusp of a major surge in solar battery adoption with SunWiz forecasting at least 100,000 home energy ...

FY 2025 HPS revenue surged 99% YoY to $1B, now representing 39% of total company revenue. Click here to find out why CLS ...